LUNG
Income statement / Annual
Last year (2024), Pulmonx Corporation's total revenue was $83.79 M,
an increase of 22.01% from the previous year.
In 2024, Pulmonx Corporation's net income was -$56.39 M.
See Pulmonx Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$83.79 M |
$68.68 M |
$53.66 M |
$48.42 M |
$32.73 M |
$32.60 M |
$20.00 M |
| Cost of Revenue |
$21.79 M
|
$17.92 M
|
$13.80 M
|
$12.79 M
|
$11.53 M
|
$10.18 M
|
$7.72 M
|
| Gross Profit |
$62.00 M
|
$50.75 M
|
$39.87 M
|
$35.63 M
|
$21.20 M
|
$22.41 M
|
$12.29 M
|
| Gross Profit Ratio |
0.74
|
0.74
|
0.74
|
0.74
|
0.65
|
0.69
|
0.61
|
| Research and Development Expenses |
$17.57 M
|
$18.08 M
|
$15.40 M
|
$13.06 M
|
$7.46 M
|
$6.05 M
|
$6.99 M
|
| General & Administrative Expenses |
$0.00
|
$89.81 M
|
$77.01 M
|
$64.77 M
|
$44.57 M
|
$34.20 M
|
$20.35 M
|
| Selling & Marketing Expenses |
$0.00
|
$4.80 M
|
$6.10 M
|
$5.10 M
|
$1.50 M
|
$600,000.00
|
$100,000.00
|
| Selling, General & Administrative Expenses |
$102.14 M
|
$94.61 M
|
$83.11 M
|
$69.87 M
|
$46.07 M
|
$34.20 M
|
$20.35 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$396,000.00
|
-$585,000.00
|
$3.28 M
|
-$617,000.00
|
-$916,000.00
|
| Operating Expenses |
$119.71 M
|
$112.69 M
|
$98.50 M
|
$82.93 M
|
$53.53 M
|
$40.25 M
|
$27.34 M
|
| Cost And Expenses |
$141.49 M
|
$130.61 M
|
$112.30 M
|
$95.72 M
|
$65.07 M
|
$50.43 M
|
$35.06 M
|
| Interest Income |
$5.06 M
|
$5.57 M
|
$1.53 M
|
$400,000.00
|
$213,000.00
|
$432,000.00
|
$21,000.00
|
| Interest Expense |
$3.51 M
|
$3.23 M
|
$1.07 M
|
$829,000.00
|
$3.18 M
|
$2.32 M
|
$2.52 M
|
| Depreciation & Amortization |
$1.49 M
|
$1.95 M
|
$4.00 M
|
$3.16 M
|
$400,000.00
|
$1.20 M
|
$270,000.00
|
| EBITDA |
-$57.70 M |
-$55.09 M |
-$55.99 M |
-$46.62 M |
-$28.44 M |
-$16.82 M |
-$15.68 M |
| EBITDA Ratio |
-0.69
|
-0.8
|
-1.07
|
-0.98
|
-0.88
|
-0.54
|
-0.78
|
| Operating Income Ratio |
-0.69
|
-0.9
|
-1.09
|
-0.98
|
-0.99
|
-0.55
|
-0.75
|
| Total Other Income/Expenses Net |
$1.81 M
|
$1.66 M
|
$67,000.00
|
-$1.01 M
|
$314,000.00
|
-$2.50 M
|
-$3.42 M
|
| Income Before Tax |
-$55.89 M
|
-$60.27 M
|
-$58.57 M
|
-$48.32 M
|
-$32.02 M
|
-$20.34 M
|
-$18.47 M
|
| Income Before Tax Ratio |
-0.67
|
-0.88
|
-1.09
|
-1
|
-0.98
|
-0.62
|
-0.92
|
| Income Tax Expense |
$500,000.00
|
$571,000.00
|
$353,000.00
|
$343,000.00
|
$213,000.00
|
$363,000.00
|
$12,000.00
|
| Net Income |
-$56.39 M
|
-$60.84 M
|
-$58.92 M
|
-$48.66 M
|
-$32.23 M
|
-$20.70 M
|
-$18.48 M
|
| Net Income Ratio |
-0.67
|
-0.89
|
-1.1
|
-1.01
|
-0.98
|
-0.64
|
-0.92
|
| EPS |
-1.44 |
-1.6 |
-1.59 |
-1.35 |
-0.9 |
-0.58 |
-0.89 |
| EPS Diluted |
-1.44 |
-1.6 |
-1.59 |
-1.35 |
-0.9 |
-0.58 |
-0.89 |
| Weighted Average Shares Out |
$39.11 M
|
$37.97 M
|
$37.10 M
|
$36.13 M
|
$35.69 M
|
$35.43 M
|
$20.71 M
|
| Weighted Average Shares Out Diluted |
$39.11 M
|
$37.97 M
|
$37.10 M
|
$36.13 M
|
$35.69 M
|
$35.43 M
|
$20.71 M
|
| Link |
|
|
|
|
|
|
|
